药品名称INTROPIN
申请号017395产品号002
活性成分DOPAMINE HYDROCHLORIDE市场状态停止上市
剂型或给药途径INJECTABLE;INJECTION规格80MG/ML
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构HOSPIRA INC
化学类型New molecular entity (NME)审评分类Priority review drug
与本品相关的专利信息(来自橙皮书Orange Book)
专利号专利过期日是否化合物专利是否产品专利专利用途代码专利下载
历史专利信息
与本品相关的市场独占权保护信息
独占权代码失效日期
历史市场独占权保护信息
与药品注册相关的信息
申请号修订号审批结论公开文档类型文档创建时间获取文档
药品注册审批历史信息
申请号修订号审批结论审批日期审批内容
017395030AP2001/11/05Control Supplement
017395029AP1997/06/17Labeling Revision
017395028AP1995/05/05Labeling Revision
017395027AP1992/10/07Labeling Revision
017395026AP1990/04/12Manufacturing Change or Addition
017395025AP1986/05/30Manufacturing Change or Addition
017395024AP1983/04/06Package Change
017395023AP1982/04/02Formulation Revision
017395022AP1982/02/08Expiration Date Change
017395021AP1981/09/15Control Supplement
017395020AP1981/07/23Manufacturing Change or Addition
017395019AP1981/11/12Labeling Revision
017395018AP1981/05/21Labeling Revision
017395017AP1981/09/15Labeling Revision
017395016AP1981/11/12General Efficacy (MarkIV)
017395015AP1980/11/14Control Supplement
017395014AP1980/01/14Labeling Revision
017395013AP1980/07/10Formulation Revision
017395012AP1980/07/10Labeling Revision
017395011AP1980/07/10Control Supplement
017395010AP1979/06/11Labeling Revision
017395009AP1979/06/11Labeling Revision
017395008AP1979/06/11Labeling Revision
017395007AP1978/08/24Control Supplement
017395006AP1977/10/06Control Supplement
017395005AP1976/01/20Manufacturing Change or Addition
017395004AP1976/05/03Labeling Revision
017395003AP1976/05/03Labeling Revision
017395002AP1975/10/07Control Supplement
017395001AP1975/04/30Labeling Revision
017395000AP1974/02/25Approval